001     164828
005     20230915090557.0
024 7 _ |a pmc:PMC9262070
|2 pmc
024 7 _ |a 10.3174/ajnr.A7555
|2 doi
024 7 _ |a 0195-6108
|2 ISSN
024 7 _ |a 1936-959X
|2 ISSN
024 7 _ |a altmetric:130476926
|2 altmetric
024 7 _ |a pmid:35772801
|2 pmid
037 _ _ |a DZNE-2022-01272
082 _ _ |a 610
100 1 _ |a Alves, C. A. P. F.
|0 0000-0001-5877-9086
|b 0
245 _ _ |a Brain Abnormalities in Patients with Germline Variants in H3F3 : Novel Imaging Findings and Neurologic Symptoms Beyond Somatic Variants and Brain Tumors
260 _ _ |a Oak Brook, Ill.
|c 2022
|b Soc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1657539785_30475
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Pathogenic somatic variants affecting the genes Histone 3 Family 3A and 3B (H3F3) are extensively linked to the process of oncogenesis, in particular related to central nervous system tumors in children. Recently, H3F3 germline missense variants were described as the cause of a novel pediatric neurodevelopmental disorder. We aimed to investigate patterns of brain MR imaging of individuals carrying H3F3 germline variants.Materials and methods: In this retrospective study, we included individuals with proved H3F3 causative genetic variants and available brain MR imaging scans. Clinical and demographic data were retrieved from available medical records. Molecular genetic testing results were classified using the American College of Medical Genetics criteria for variant curation. Brain MR imaging abnormalities were analyzed according to their location, signal intensity, and associated clinical symptoms. Numeric variables were described according to their distribution, with median and interquartile range.Results: Eighteen individuals (10 males, 56%) with H3F3 germline variants were included. Thirteen of 18 individuals (72%) presented with a small posterior fossa. Six individuals (33%) presented with reduced size and an internal rotational appearance of the heads of the caudate nuclei along with an enlarged and squared appearance of the frontal horns of the lateral ventricles. Five individuals (28%) presented with dysgenesis of the splenium of the corpus callosum. Cortical developmental abnormalities were noted in 8 individuals (44%), with dysgyria and hypoplastic temporal poles being the most frequent presentation.Conclusions: Imaging phenotypes in germline H3F3-affected individuals are related to brain features, including a small posterior fossa as well as dysgenesis of the corpus callosum, cortical developmental abnormalities, and deformity of lateral ventricles.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
650 _ 2 |a Brain: diagnostic imaging
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
650 _ 2 |a Brain Neoplasms: diagnostic imaging
|2 MeSH
650 _ 2 |a Brain Neoplasms: genetics
|2 MeSH
650 _ 2 |a Brain Neoplasms: pathology
|2 MeSH
650 _ 2 |a Child
|2 MeSH
650 _ 2 |a Germ Cells: pathology
|2 MeSH
650 _ 2 |a Histones: genetics
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Malformations of Cortical Development: pathology
|2 MeSH
650 _ 2 |a Neurodevelopmental Disorders: pathology
|2 MeSH
650 _ 2 |a Retrospective Studies
|2 MeSH
700 1 _ |a Sherbini, O.
|b 1
700 1 _ |a D’Arco, F.
|b 2
700 1 _ |a Steel, D.
|0 0000-0003-0942-7943
|b 3
700 1 _ |a Kurian, M. A.
|0 0000-0003-3529-5075
|b 4
700 1 _ |a Radio, F. C.
|b 5
700 1 _ |a Ferrero, G. B.
|0 0000-0002-3793-5788
|b 6
700 1 _ |a Carli, D.
|0 0000-0001-5690-6504
|b 7
700 1 _ |a Tartaglia, M.
|0 0000-0001-7736-9672
|b 8
700 1 _ |a Balci, T. B.
|0 0000-0002-5409-8387
|b 9
700 1 _ |a Powell-Hamilton, N. N.
|b 10
700 1 _ |a Schrier Vergano, S. A.
|b 11
700 1 _ |a Reutter, H.
|b 12
700 1 _ |a Hoefele, J.
|0 0000-0002-7917-7129
|b 13
700 1 _ |a Günthner, R.
|b 14
700 1 _ |a Roeder, E. R.
|0 0000-0002-8439-657X
|b 15
700 1 _ |a Littlejohn, R. O.
|0 0000-0001-8000-0446
|b 16
700 1 _ |a Lessel, D.
|0 0000-0003-4496-244X
|b 17
700 1 _ |a Lüttgen, S.
|0 0000-0002-9902-7697
|b 18
700 1 _ |a Kentros, C.
|0 0000-0001-6316-6997
|b 19
700 1 _ |a Anyane-Yeboa, K.
|0 0000-0002-4977-9719
|b 20
700 1 _ |a Catarino, C. B.
|0 0000-0002-6528-7570
|b 21
700 1 _ |a Mercimek-Andrews, S.
|0 0000-0001-8396-6764
|b 22
700 1 _ |a Denecke, Jannis
|0 P:(DE-2719)2812081
|b 23
|u dzne
700 1 _ |a Lyons, M. J.
|0 0000-0002-8644-5507
|b 24
700 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 25
|u dzne
700 1 _ |a Bhoj, E. J.
|0 0000-0001-5748-3507
|b 26
700 1 _ |a Bryant, L.
|0 0000-0001-8483-8940
|b 27
700 1 _ |a Vanderver, A.
|0 0000-0002-6290-6751
|b 28
773 _ _ |a 10.3174/ajnr.A7555
|g Vol. 43, no. 7, p. 1048 - 1053
|0 PERI:(DE-600)2025541-X
|n 7
|p 1048 - 1053
|t American journal of neuroradiology
|v 43
|y 2022
|x 0195-6108
909 C O |o oai:pub.dzne.de:164828
|p VDB
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 23
|6 P:(DE-2719)2812081
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 25
|6 P:(DE-2719)2810704
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AM J NEURORADIOL : 2021
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-16
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-16
920 1 _ |0 I:(DE-2719)1111015
|k AG Höglinger 2
|l Coordinator of Clinical Parkinson Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21